Lee Hartwell, Nobelist and President and Director, Fred Hutchinson Cancer Research Center; with Nancy E. Stagliano, CEO, CytomX Therapeutics; and Yulun Wang, Chairman and CEO, InTouch Health; hosted by Keith Seinfeld, Science and Health Reporter, KPLU radio.
Lee Hartwell, Nobelist and President and Director, Fred Hutchinson Cancer Research Center; with Nancy E. Stagliano, CEO, CytomX Therapeutics; and Yulun Wang, Chairman and CEO, InTouch Health; hosted by Keith Seinfeld, Science and Health Reporter, KPLU radio.
In this interview from ASH 2011, Dr. Bart Scott, an expert in bone marrow failure from the Fred Hutchinson Cancer Research Center, helps us understand where bone marrow transplantation fits in with treatment for myelodysplastic syndrome (MDS). The discussion includes reduced intensity transplant for patients who may not be able to tolerate the high dose chemotherapy associated with traditional bone marrow transplant.
In this interview from ASH 2011, Dr. Bart Scott, an expert in bone marrow failure from the Fred Hutchinson Cancer Research Center, helps us understand where bone marrow transplantation fits in with treatment for myelodysplastic syndrome (MDS). The discussion includes reduced intensity transplant for patients who may not be able to tolerate the high dose chemotherapy associated with traditional bone marrow transplant.
New clinical trials data presented at ASCO 2011 revealed a striking response to drugs ipilimumab (recently-approved), and vemurafenib, a new drug for patients with the most common subtype of advanced melanoma (B-RAF V600E Mutation). Dr. Kim Margolin, a Melanoma specialist at the Fred Hutchinson Cancer Research Institute in Seattle helped us understand why this new drug is making news and why patients have reason to be hopeful.
New clinical trials data presented at ASCO 2011 revealed a striking response to drugs ipilimumab (recently-approved), and vemurafenib, a new drug for patients with the most common subtype of advanced melanoma (B-RAF V600E Mutation). Dr. Kim Margolin, a Melanoma specialist at the Fred Hutchinson Cancer Research Institute in Seattle helped us understand why this new drug is making news and why patients have reason to be hopeful.
Short documentary follows a group of 9th grade Cleveland High School students as they discover flow Cytometry while touring The Fred Hutchinson Cancer Research Center in Seattle, WA. Led by their teacher, Jeff Shaver PHD, (PLTW Biomedical Science Teacher) they meet scientists and learn about possibilities of using a flow cytometer for scientific research.
Produced by: Jeff Shaver PHD and Washington STEM
Directed by: Ryan K Adams, Block My Eye Films
Music…
Short documentary follows a group of 9th grade Cleveland High School students as they discover flow Cytometry while touring The Fred Hutchinson Cancer Research Center in Seattle, WA. Led by their teacher, Jeff Shaver PHD, (PLTW Biomedical Science Teacher) they meet scientists and learn about possibilities of using a flow cytometer for scientific research.
Produced by: Jeff Shaver PHD and Washington STEM
Directed by: Ryan K Adams, Block My Eye Films
Music by: Garret Fisher
Director Of Photography: Jacob Rosen (Jeff Shaver Interview)
Audio Recordist: Jacob Arthur Sunday (Jeff Shaver Interview)
